Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis

Cellular Microbiology

Volumn 7, Issue 4, 2005, Pages 499-510

  Park, Hyunsook ^a   Myers, Carter L ^a   Sheppard, Donald C ^a   Phan, Quynh T ^a   Sanchez, Angela A ^a   Edwards Jr , John E ^a,b   Filler, Scott G ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; RAS PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EFG1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CELL DAMAGE; CELL INTERACTION; CELL INVASION; CONTROLLED STUDY; DISEASE MODEL; EPITHELIUM CELL; FEMALE; FUNGAL VIRULENCE; FUNGUS HYPHAE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; MOUTH MUCOSA; NONHUMAN; OROPHARYNX; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; STRAIN DIFFERENCE; THRUSH; WILD TYPE;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MICE; MICE, INBRED BALB C; MOUTH; PROTEIN-SERINE-THREONINE KINASES; RAS PROTEINS; TRANSCRIPTION FACTORS; VIRULENCE;

CANDIDA ALBICANS; MURINAE;

EID: 15944381558     PISSN: 14625814     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2004.00476.x     Document Type: Article

References (54)

1. Bahn, Y.S., and Sundstrom, P. (2001) CAP1, an adenylate cyclase-associated protein gene, regulates bud-hypha transitions, filamentous growth, and cyclic AMP levels and is required for virulence of Candida albicans. J Bacteriol 183: 3211-3223.
2. Bahn, Y.S., Staab, J., and Sundstrom, P. (2003) Increased high-affinity phosphodiesterase PDE2 gene expression in germ tubes counteracts CAP1-dependent synthesis of cyclic AMP, limits hypha production and promotes virulence of Candida albicans. Mol Microbiol 50: 391-409.
3. Belanger, P.H., Johnston, D., Fratti, R.A., Zhang, M., and Filler, S.G. (2002) Enclocytosis of Candida albicans by vascular endothelial cells is associated with tyrosine phosphorylation of specific host cell proteins. Cell Microbiol 4: 805-812.
4. Bockmuhl, D.P., Krishnamurthy, S., Gerads, M., Sonneborn, A., and Ernst, J.F. (2001) Distinct and redundant roles of the two protein kinase A isoforms Tpk1p and Tpk2p in morphogenesis and growth of Candida albicans. Mol Microbiol 42: 1243-1257.
5. Braun, B.R., and Johnson, A.D. (1997) Control of filament formation in Candida albicans by the transcriptional repressor Tup1. Science 277: 105-109.
6. Braun, B.R., and Johnson, A.D. (2000) TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 155: 57-67.
7. Cheng, S., Nguyen, M.H., Zhang, Z., Jia, H., Handfield, M., and Clancy, C.J. (2003) Evaluation of the roles of four Candida albicans genes in virulence by using gene disruption strains that express URA3 from the native locus. Infect Immun 71: 6101-6103.
8. Cloutier, M., Castilla, R., Bolduc, N., Zelada, A., Martineau, P., Bouillon, M., et al. (2003) The two isoforms of the cAMP-dependent protein kinase catalytic subunit are involved in the control of dimorphism in the human fungal pathogen Candida albicans. Fungal Genet Biol 38: 133-141.
9. Deighton, F.J., Hall, N.K., and Larsh, H.W. (1979) Merthiolate treatment of pathogenic fungi. J Clin Microbiol 10: 144-146.
10. Dickson, M.A., Hahn, W.C., Ino, Y., Ronfard, V., Wu, J.Y., Weinberg, R.A., et al. (2000) Human keratinocytes that express hTERT and also bypass a p16 (INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20: 1436-1447.
11. Dieterich, C., Schandar, M., Noll, M., Johannes, F.J., Brunner, H., Graeve, T., and Rupp, S. (2002) In vitro reconstructed human epithelia reveal contributions of Candida albicans EFG1 and CPH1 to adhesion and invasion. Microbiology 148: 497-506.
12. Drago, L., Mombelli, B., De Vecchi, E., Bonaccorso, C., Fassina, M.C., and Gismondo, M.R. (2000) Candida albicans cellular internalization: a new pathogenic factor? Int J Antimicrob Agents 16: 545-547.
13. Enache, E., Eskandari, T., Borja, L., Wadsworth, E., Hoxter, B., and Calderone, R. (1996) Candida albicans adherence to a human oesophageal cell line. Microbiology 142: 2741-2746.
14. Eversole, L.R., Reichart, P.A., Ficarra, G., Schmidt-Westhausen, A., Romagnoli, P., and Pimpinelli, N. (1997) Oral keratinocyte immune responses in HIV-associated candidiasis. Oral Surg Oral Med O 84: 372-380.
15. Farah, C.S., Ashman, R.B., and Challacombe, S.J. (2000) Oral candidosis. Clin Dermatol 18: 553-562.
16. Felk, A., Kretschmar, M., Albrecht, A., Schaller, M., Beinhauer, S., Nichterlein, T., et al. (2002) Candida albicans hyphal formation and the expression of the Efg1 -regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun 70: 3689-3700.
17. Feng, Q., Summers, E., Guo, B., and Fink, G. (1999) Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J Bacteriol 181: 6339-6346.
18. Filler, S.G., Der, L.C., Mayer, C.L., Christenson, P.D., and Edwards, J.E., Jr (1987) An enzyme-linked immunosorbent assay for quantifying adherence of Candida to human vascular endothelium. J Infect Dis 156: 561-566.
19. Filler, S.G., Ibe, B.O., Luckett, P.M., Raj, J.U., and Edwards, J.E., Jr (1991) Candida albicans stimulates endothelial cell eicosanoid production. J Infect Dis 164: 928-935.
20. Filler, S.G., Swerdloff, J.N., Hobbs, C., and Luckett, P.M. (1995) Penetration and damage of endothelial cells by Candida albicans. Infect Immun 63: 976-983.
21. Fonzi, W.A., and Irwin, M.Y. (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728.
22. Fratti, R.A., Ghannoum, M.A., Edwards, J.E., Jr and Filler, S.G. (1996) Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect Immun 64: 4714-4718.
23. Fu, Y., Ibrahim, A.S., Sheppard, D.C., Chen, Y.C., French, S.W., Cutler, J.E., et al. (2002) Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol Microbiol 44: 61-72.
24. Ibrahim, A.S., Mirbod, F., Filler, S.G., Banno, Y., Cole, G.T., Kitajima, Y., et al. (11995) Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 63: 1993-1998.
25. Ibrahim, A.S., Filler, S.G., Sanglard, D., Edwards, J.E., Jr and Hube, B. (1998) Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells. Infect Immun 66: 3003-3005.
26. Kamai, Y., Kubota, M., Hosokawa, T., Fukuoka, T., and Filler, S.G. (2001) New model of oropharyngeal candidiasis in mice. Antimicrob Agents Chemother 45: 3195-3197.
27. Kamai, Y., Kubota, M., Hosokawa, T., Fukuoka, T., and Filler, S.G. (2002) Contribution of Candida albicans ALS1 to the pathogenesis of experimental oropharyngeal candidiasis. Infect Immun 70: 5256-5258.
28. Korting, H.C., Hube, B., Oberbauer, S., Januschke, E., Hamm, G., Albrecht, A., et al. (2003) Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium. J Med Microbiol 52: 623-632.
29. Lachke, S.A., Srikantha, T., and Soll, D.R. (2003) The regulation of EFG1 in white-opaque switching in Candida albicans involves overlapping promoters. Mol Microbiol 48: 523-536.
30. Lo, H.J., Kohler, J.R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A., and Fink, G.R. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
31. Lopes-Bezerra, L.M., and Filler, S.G. (2004) Interactions of Aspergillus Fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity. Blood 72: 598-601.
32. Navarro-Garcia, F., Sanchez, M., Nombela, C., and Pla, J. (2001) Virulence genes in the pathogenic yeast Candida albicans. FEMS Microbiol Rev 25: 245-268.
33. Phan, Q.T., Belanger, P.H., and Filler, S.G. (2000) Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 68: 3485-3490.
34. Redding, S.W., Zellars, R.C., Kirkpatrick, W.R., McAtee, R.K., Caceres, M.A., Fothergill, A.W., et al. (1999) Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 37: 3896-3900.
35. Rotrosen, D., Edwards, J.E., Jr, Gibson, T.R., Moore, J.C., Cohen, A.H., and Green, I. (1985) Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J Infect Dis 152: 1264-1274.
36. Sanchez, A.A., Johnston, D.A., Myers, C., Edwards, J.E., Jr, Mitchell, A.P., and Filler, S.G. (2004) Relationship between Candida albicans virulence during experimental hematogenously disseminated Infection and endothelial cell damage In vitro. Infect Immun 72: 598-601.
37. Sangeorzan, J.A., Bradley, S.F., He, X., Zarins, L.T., Ridenour, G.L., Tiballi, R.N., and Kauffman, C.A. (1994) Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 97: 339-346.
38. Schaller, M., Korting, H.C., Schafer, W., Bastert, J., Chen, W., and Hube, B. (1999) Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 34: 169-180.
39. Schroppel, K., Sprosser, K., Whiteway, M., Thomas, D.Y., Rollinghoff, M., and Csank, C. (2000) Repression of hyphal proteinase expression by the mitogen-activated protein (MAP) kinase phosphatase Cpp1p of Candida albicans is independent of the MAP kinase Cek1p. Infect Immun 68: 7159-7161.
40. Sharkey, L.L., McNemar, M.D., Saporito-Irwin, S.M., Sypherd, P.S., and Fonzi, W.A. (1999) HWP1 functions in the morphological development of Candida albicans down-stream of EFG 1, TUP 1, and RBF1. J Bacteriol 181: 5273-5279.
41. Sheppard, D.C., Yeaman, M.R., Welch, W.H., Phan, Q.T., Fu, Y., Ibrahim, A.S., et al. (2004) Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem 279: 30840-30849.
42. Sonneborn, A., Bockmuhl, D.P., and Ernst, J.F. (1999a) Chlamydospore formation in Candida albicans requires the Efg1p morphogenetic regulator. Infect Immun 67: 5514-5517.
43. Sonneborn, A., Tebarth, B., and Ernst, J.F. (1999b) Control of white-opaque phenotypic switching in Candida albicans by the Efg1p morphogenetic regulator. Infect Immun 67: 4655-4660.
44. Sonneborn, A., Bockmuhl, D.P., Gerads, M., Kurpanek, K., Sanglard, D., and Ernst, J.F. (2000) Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans. Mol Microbiol 35: 386-396.
45. Staab, J.F., and Sundstrom, P. (2003) URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes. Trends Microbiol 11: 69-73.
46. Staib, P., Kretschmar, M., Nichterlein, T., Hof, H., and Morschhauser, J. (2002) Transcriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infection. Infect Immun 70: 921-927.
47. Stoldt, V.R., Sonneborn, A., Leuker, C.E., and Ernst, J.F. (1997) Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 16: 1982-1991.
48. Sundstrom, P., Balish, E., and Allen, C.M. (2002a) Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J Infect Dis 185: 521-530.
49. Sundstrom, P., Cutler, J.E., and Staab, J.F. (2002b) Reevaluation of the role of HWP1 in systemic candidiasis by use of Candida albicans strains with selectable marker URA3 targeted to the ENO1 locus. Infect Immun 70: 3281-3283.
50. Tebarth, B., Doedt, T., Krishnamurthy, S., Weide, M., Monterola, F., Dominguez, A., and Ernst, J.F. (2003) Adaptation of the Efg1p morphogenetic pathway in Candida albicans by negative autoregulation and PKA-dependent repression of the EFG1 gene. J Mol Biol 329: 949-962.
51. Tsuchimori, N., Sharkey, L.L., Fonzi, W.A., French, S.W., Edwards, J.E., Jr, and Filler, S.G. (2000) Reduced virulence of HWP1 deficient mutants of Candida albicans and their interactions with host cells. Infect Immun 68: 1997-2002.
52. Weide, M.R., and Ernst, J.F. (1999) Caco-2 monolayer as a model for transepithelial migration of the fungal pathogen Candida albicans. Mycoses 42 (Suppl. 2): 61-67.
53. Wilson, R.B., Davis, D., Enloe, B.M., and Mitchell, A.P. (2000) A recyclable Candida albicans URA3 cassette for PCR product-directed gene disruptions. Yeast 16: 65-70.
54. Wright, W.L., and Wenzel, R.P. (1997) Nosocomial Candida. Epidemiology, transmission, and prevention. Infect Dis Clin North Am 11: 411-425.